Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1531 AL 1545

Memantine for the patients with mild cognitive impairment in Parkinson's disease: a pharmacological fMRI study

Kawashima S; RCIP-Nagoya Study Group; Matsukawa N.

BMC Neurol. 2022 May 13;22(1):175. doi: 10.1186/s12883-022-02699-x.

Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson's Disease

Guatteo E, Berretta N, Monda V, Ledonne A, Mercuri NB.

Int J Mol Sci. 2022 Apr 19;23(9):4508. doi: 10.3390/ijms23094508.

Demystifying the Neuroprotective Role of Neuropeptides in Parkinson's Disease: A Newfangled and Eloquent Therapeutic Perspective

Behl T, Madaan P, Sehgal A, Singh S, Makeen HA, Albratty M, Alhazmi HA, Meraya AM, Bungau S.

Int J Mol Sci. 2022 Apr 20;23(9):4565. doi: 10.3390/ijms23094565.

AGEomics Biomarkers and Machine Learning-Realizing the Potential of Protein Glycation in Clinical Diagnostics

Rabbani N.

Int J Mol Sci. 2022 Apr 21;23(9):4584. doi: 10.3390/ijms23094584.

Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases

Doroszkiewicz J, Groblewska M, Mroczko B.

Int J Mol Sci. 2022 Apr 21;23(9):4610. doi: 10.3390/ijms23094610.

Soluble Epoxide Hydrolase as a Therapeutic Target for Neuropsychiatric Disorders

Shan J, Hashimoto K.

Int J Mol Sci. 2022 Apr 29;23(9):4951. doi: 10.3390/ijms23094951.

Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism

Olivo E, La Chimia M, Ceramella J, Catalano A, Chiaradonna F, Sinicropi MS, Cuda G, Iacopetta D, Scumaci D.

Cells. 2022 Apr 23;11(9):1432. doi: 10.3390/cells11091432.

Applying a Fast-Scan Cyclic Voltammetry to Explore Dopamine Dynamics in Animal Models of Neuropsychiatric Disorders

Grinevich VP, Zakirov AN, Berseneva UV, Gerasimova EV, Gainetdinov RR, Budygin EA.

Cells. 2022 May 3;11(9):1533. doi: 10.3390/cells11091533.

The Therapeutic Role of Ketogenic Diet in Neurological Disorders

Pietrzak D, Kasperek K, Rękawek P, Piątkowska-Chmiel I.

Nutrients. 2022 May 6;14(9):1952. doi: 10.3390/nu14091952.

Pathophysiological Role and Medicinal Chemistry of A(2A) Adenosine Receptor Antagonists in Alzheimer's Disease

Merighi S, Borea PA, Varani K, Vincenzi F, Travagli A, Nigro M, Pasquini S, Suresh RR, Kim SW, Volkow ND, Jacobson KA, Gessi S.

Molecules. 2022 Apr 21;27(9):2680. doi: 10.3390/molecules27092680.

Effect of activity-based training versus strengthening exercises on upper extremity functions in Parkinson's patients; A randomized controlled, single blind, superiority trial

Zare M, Özdemir H, Tavşan MY, Tuna F, Süt N, Güler S, Kabayel DD.

Clin Neurol Neurosurg. 2022 Jul;218:107261. doi: 10.1016/j.clineuro.2022.107261. Epub 2022 Apr 29.

Evaluation of an individualized, tablet-based physiotherapy training programme for patients with Parkinson's disease: the ParkProTrain study, a quasi-randomised controlled trial

Wagner L, Hauptmann B, Hoffmann AK, Jochems N, Schmeier B, Schrader A, Kohlmann T, Deck R.

BMC Neurol. 2022 May 14;22(1):176. doi: 10.1186/s12883-022-02647-9.

Action and emotion perception in Parkinson's disease: A neuroimaging meta-analysis

Arioli M, Cattaneo Z, Rusconi ML, Blandini F, Tettamanti M.

Neuroimage Clin. 2022;35:103031. doi: 10.1016/j.nicl.2022.103031. Epub 2022 May 5.

Vitamin B6 Deficiency Anemia Attributed to Levodopa/Carbidopa Intestinal Gel Therapy for Parkinson's Disease: A Diagnostic Pitfall for Myelodysplastic Syndrome with Ring Sideroblasts

Yasuda H, Hatano T, Honda T, Tsutsui M, Hattori N, Ando M, Komatsu N.

Intern Med. 2022 Dec 15;61(24):3719-3722. doi: 10.2169/internalmedicine.9577-22. Epub 2022 May 14.

New Insights and Implications of Natural Killer Cells in Parkinson's Disease

Menees KB, Lee JK.

J Parkinsons Dis. 2022;12(s1):S83-S92. doi: 10.3233/JPD-223212.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias